Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Submitted by
admin
on November 17, 2015 - 5:57pm
Source:
Fierce Pharma
News Tags:
Bristol-Myers Squibb
FDA
priority review
Opdivo
kidney cancer
Headline:
Bristol-Myers nabs FDA priority review for new Opdivo use in kidney cancer
Do Not Allow Advertisers to Use My Personal information
